The PBS paradox - a rising medicine spend, but a shrinking investment capacity

The fourth in this week’s series, building on earlier pieces, brings the focus squarely onto the PBS, arguing that spending on medicines has not truly slowed, but has shifted decisively from government to consumers, reshaping how the PBS functions, what it can fund, and the policy choices now confronting decision-makers. …